Health care stocks were advancing in Tuesday afternoon trading, with the NYSE Health Care Index adding 0.4% and the Health Care Select Sector SPDR Fund (XLV) up 0.1%.
The iShares Biotechnology ETF (IBB) fell 0.7%.
In corporate news, Janux Therapeutics (JANX) shares soared 56%. The company reported late Monday positive interim clinical data for its JANX007 clinical program in prostate cancer patients.
Rezolute (RZLT) shares jumped 5.8% after the company said Tuesday the US Food and Drug Administration granted orphan drug designation to ersodetug to treat hypoglycemia caused by tumor hyperinsulinism.
TransMedics' (TMDX) shares tumbled past 15% in recent trading, a day after the company said it named Gerardo Hernandez as chief financial officer.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.